RMTG (Regenerative Medical Technology Group) LT-Debt-to-Total-Asset: 0.48 (As of Mar. 2026)


What is Regenerative Medical Technology Group LT-Debt-to-Total-Asset?

Regenerative Medical Technology Group RMTG -25.17% LT-Debt-to-Total-Asset is 0.48 as of Mar. 2026. The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Regenerative Medical Technology Group's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.48.

Regenerative Medical Technology Group's long-term debt to total assets ratio declined from Mar. 2025 (0.56) to Mar. 2026 (0.48). It may suggest that Regenerative Medical Technology Group is progressively becoming less dependent on debt to grow their business.

Regenerative Medical Technology Group  (OTCPK:RMTG) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Regenerative Medical Technology Group LT-Debt-to-Total-Asset Related Terms

Regenerative Medical Technology Group LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Regenerative Medical Technology Group's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerative Medical Technology Group LT-Debt-to-Total-Asset Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only 1.27 1.00 0.84 0.58 0.54

Regenerative Medical Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.66 3.83 0.54 0.48

Regenerative Medical Technology Group LT-Debt-to-Total-Asset Calculation

Regenerative Medical Technology Group's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=2.409/4.489
=0.54

Regenerative Medical Technology Group's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=2.426/5.01
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.48 mean?
Regenerative Medical Technology Group (RMTG) has a LT-Debt-to-Total-Asset of 0.48 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Regenerative Medical Technology Group and its competitors.
Is Regenerative Medical Technology Group's LT-Debt-to-Total-Asset too high?
Regenerative Medical Technology Group's current LT-Debt-to-Total-Asset is 0.48.
How does Regenerative Medical Technology Group's LT-Debt-to-Total-Asset compare to PTIX and CERO?
Regenerative Medical Technology Group's LT-Debt-to-Total-Asset of 0.48 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Regenerative Medical Technology Group and its competitors. Regenerative Medical Technology Group's current LT-Debt-to-Total-Asset is 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerative Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Possible Value Trap. The stock's GF Value™ is $0.06, compared to a current price of $0.02 — trading 64.3% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current LT-Debt-to-Total-Asset is 0.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.